Melanocortins in fibroblast biology – current update and future perspective for dermatology

    October 2004 in “ Experimental Dermatology
    Markus Böhm, Thomas A. Luger
    TLDR α-MSH may help treat skin inflammation and fibrosis.
    The document discussed the role of proopiomelanocortin (POMC)-derived peptides, particularly α-melanocyte-stimulating hormone (α-MSH), in skin biology, focusing on human dermal fibroblasts (HDFs) and their expression of melanocortin receptors (MC-Rs). It was found that α-MSH had anti-inflammatory effects on fibroblastic skin cells by reducing IL-8 production and other inflammatory responses. Additionally, α-MSH counteracted the effects of transforming growth factor-β 1 on collagen synthesis, showing antifibrogenic activity in a mouse model. These findings suggested that α-MSH could modulate inflammatory and fibrogenic responses in the skin, offering potential new therapeutic approaches for treating fibrotic skin disorders and inflammatory diseases of the hair follicle.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results